BETA Beta Drugs Ltd. NSE · India

Beta Drugs (BETA) news

Top story · Aug 12, 2026 · SEC filing 8-K

Beta Drugs reports results

In the press release, the Company also announced that it will hold a conference call on August 12, 2026 to discuss its financial and operating results for the quarter ended June 30, 2026.

Source: 8-K filed Aug 12, 2026 on SEC EDGAR

Latest Beta Drugs news

We have not published a story on Beta Drugs yet. When there is news, it will appear here.

Questions about Beta Drugs

What is the ticker symbol of Beta Drugs?

Beta Drugs Ltd. trades under the ticker BETA on NSE.

Where is Beta Drugs listed?

Beta Drugs Ltd. is listed on NSE.

Which country or territory is Beta Drugs listed under?

Our directory records Beta Drugs Ltd. under India.

What does Beta Drugs do?

Our directory classifies Beta Drugs Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Beta Drugs?

The ISIN recorded for Beta Drugs Ltd. is INE351Y01019.

Does aibio.space cover Beta Drugs?

aibio.space lists Beta Drugs Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Beta Drugs?

Companies in our directory listed in the same country and business area as Beta Drugs: Indegene, PFIZER LIMITED, Emcure Pharmaceuticals, Alembic Pharmaceuticals, Innova Captab, Astonea Labs.

Investor discussion: Beta Drugs

Members talk about Beta Drugs (BETA). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NSE:BETA on TradingView.

Listing details

Beta Drugs Ltd. is a public biotech or pharmaceutical company listed on NSE under the ticker BETA, recorded under India. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company: Beta Drugs Ltd.
Ticker: BETA
Listing: NSE
Country or territory: India
Business scope: Pharmaceuticals: Major
ISIN: INE351Y01019
Last quote in directory: 2026-10-22
Directory source: Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction